Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yuan Ding, Tingbo Fu, Wenbin Zhou, Xiaobo Zhang, Ruying Wang & Huiying Liao. (2023) Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Lea Sacca, George Doumat, Alaa Rihan, Jonathan Maroun & Chinenye Ejezie. (2023) Examining Health Promotion Theories, Limitations, and Lessons Learned for HPV Vaccination Interventions among College Students in the United States: A Systematic Literature Review. American Journal of Health Education 54:3, pages 179-197.
Read now
Read now
Melissa L. Harry, Stephen E. Asche, Laura A. Freitag, JoAnn M. Sperl-Hillen, Daniel M. Saman, Heidi L. Ekstrom, Ella A. Chrenka, Anjali R. Truitt, Clayton I. Allen, Patrick J. O’Connor, Steven P. Dehmer, Joseph A. Bianco & Thomas E. Elliott. (2022) Human Papillomavirus vaccination clinical decision support for young adults in an upper midwestern healthcare system: a clinic cluster-randomized control trial. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Robert A. Bednarczyk. (2019) Addressing HPV vaccine myths: practical information for healthcare providers. Human Vaccines & Immunotherapeutics 15:7-8, pages 1628-1638.
Read now
Read now
Min-Young Yang, Jin-Hwa Son, Gun-Wook Kim, Hoon-Soo Kim, Hyun-Chang Ko, Moon-Bum Kim, Kyung-Min Lim & Byung-Soo Kim. (2019) Quadrivalent human papilloma virus vaccine for the treatment of multiple warts: a retrospective analysis of 30 patients. Journal of Dermatological Treatment 30:4, pages 405-409.
Read now
Read now
Angela Meggiolaro, Giuseppe Migliara & Giuseppe La Torre. (2018) Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review. Human Vaccines & Immunotherapeutics 14:5, pages 1266-1274.
Read now
Read now
E. D. Moreira, A. R. Giuliano, J. de Hoon, O.-E. Iversen, E. A. Joura, J. Restrepo, P. Van Damme, C. Vandermeulen, M. C. Ellison, A. Krick, C. Shields, B. Heiles & A. Luxembourg. (2018) Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age. Human Vaccines & Immunotherapeutics 14:2, pages 396-403.
Read now
Read now
Alain Luxembourg & Erin Moeller. (2017) 9-Valent human papillomavirus vaccine: a review of the clinical development program. Expert Review of Vaccines 16:11, pages 1119-1139.
Read now
Read now
Articles from other publishers (49)
Kimberly McNally, Ali Weinstein, Lisa Lindley, Robin Wallin & Amira Roess. (2023) A Multilevel Analysis of School-Level Human Papillomavirus Vaccination Coverage in Virginia. The Journal of School Nursing.
Crossref
Crossref
Sz-An Tsai, Chun-Yi Lu, Tzu-I Chen, Shih-Pei Huang & Yong-Chen Chen. (2023) Adverse events from HPV vaccination in Taiwan. Vaccine 41:49, pages 7444-7449.
Crossref
Crossref
Ling Han & Bingyi Zhang. (2023) Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect. Infectious Agents and Cancer 18:1.
Crossref
Crossref
Lauri E. MarkowitzElizabeth R. Unger. (2023) Human Papillomavirus Vaccination. New England Journal of Medicine 388:19, pages 1790-1798.
Crossref
Crossref
David Viveros-Carreño, Andreina Fernandes & Rene Pareja. (2023) Updates on cervical cancer prevention. International Journal of Gynecologic Cancer 33:3, pages 394-402.
Crossref
Crossref
Linda M. Niccolai, Nicholaus P. Johnson, Ashlynn Torres, Erin L. Sullivan & Caitlin E. Hansen. (2023) Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review. Journal of Adolescent Health 72:3, pages 334-343.
Crossref
Crossref
Sameer Vali Gopalani, Amanda E. Janitz, Margie Burkhart, Janis E. Campbell, Sixia Chen, Sydney A. Martinez, Ashley H. White, Amber S. Anderson, Stephanie F. Pharr, Jennifer D. Peck & Ashley Comiford. (2022) HPV vaccination coverage and factors among American Indians in Cherokee Nation. Cancer Causes & Control 34:3, pages 267-275.
Crossref
Crossref
Sarah Marshall, Aoife Fleming, Laura J. Sahm & Anne C. Moore. (2023) Identifying intervention strategies to improve HPV vaccine decision-making using behaviour change theory. Vaccine 41:7, pages 1368-1377.
Crossref
Crossref
Ojone Illah & Adeola Olaitan. (2023) Updates on HPV Vaccination. Diagnostics 13:2, pages 243.
Crossref
Crossref
John T. Schiller, Lauri E. Markowitz, Aimée R. Kreimer & Douglas R. Lowy. 2023. Plotkin's Vaccines. Plotkin's Vaccines
484
513.e11
.
Soudabeh Yarmohammadi, Mohtasham Ghaffari, Yadollah Mehrabi, Samira Mousavi & Ali Ramezankhani. (2022) Designing and psychometric assessment of the scale of factors influencing HPV vaccine uptake behaviors in young adults. Infectious Agents and Cancer 17:1.
Crossref
Crossref
Maria Wemrell & Lena Gunnarsson. (2022) Attitudes Toward HPV Vaccination in Sweden: A Survey Study. Frontiers in Public Health 10.
Crossref
Crossref
Pierre Coursaget & Antoine Touzé. (2022) Vaccins et vaccination contre les papillomavirus. Revue Francophone des Laboratoires 2022:540, pages 61-70.
Crossref
Crossref
Lawrence B. Afrin, Tania T. Dempsey & Leonard B. Weinstock. (2022) Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?. Vaccines 10:1, pages 127.
Crossref
Crossref
Vimalanand S. Prabhu, Neha Bansal, Zhiwen Liu, Rodney Finalle, Martin Sénécal, Smita Kothari, Kemar Trowers & Evan Myers. (2021) HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States. BMC Public Health 21:1.
Crossref
Crossref
Elissa Meites, Laura Stone, Raiza Amiling, Vidisha Singh, Elizabeth R Unger, Craig S Derkay & Lauri E Markowitz. (2021) Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States. Clinical Infectious Diseases 73:5, pages 885-890.
Crossref
Crossref
Barbara J. Kuter, Suzanne M. Garland, Anna R. Giuliano & Margaret A. Stanley. (2021) Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?. Preventive Medicine 144, pages 106321.
Crossref
Crossref
Arnaud John Kombe Kombe, Bofeng Li, Ayesha Zahid, Hylemariam Mihiretie Mengist, Guy-Armel Bounda, Ying Zhou & Tengchuan Jin. (2021) Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Frontiers in Public Health 8.
Crossref
Crossref
Anastasia Phillips, Megan Hickie, James Totterdell, Julia Brotherton, Aditi Dey, Richard Hill, Tom Snelling & Kristine Macartney. (2020) Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine 38:38, pages 6038-6046.
Crossref
Crossref
Liqin Cheng, Yan Wang & Juan Du. (2020) Human Papillomavirus Vaccines: An Updated Review. Vaccines 8:3, pages 391.
Crossref
Crossref
María Leticia Saucedo-Mendiola, José Luis Ríos-Bañuelos, Alejandra Vázquez-Vázquez, Elva Marcela Coria-Quiñones, María Estela Frías-Zepeda, Jesús Alonso Gándara-Mireles & Adolfo Padilla-Mendiola. 2020. Viruses and Viral Infections in Developing Countries. Viruses and Viral Infections in Developing Countries.
Cecilia M. Egoavil, José Tuells, Juan José Carreras, Emilia Montagud, Eliseo Pastor-Villalba, Pablo Caballero & Andreu Nolasco. (2020) Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018). Vaccines 8:1, pages 117.
Crossref
Crossref
Mindy S. Christianson, Patricia Wodi, Kawsar Talaat & Neal Halsey. (2020) Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence. American Journal of Obstetrics and Gynecology 222:3, pages 239-244.
Crossref
Crossref
Alexandru Barboi, Christopher H. Gibbons, Felicia Axelrod, Eduardo E. Benarroch, Italo Biaggioni, Mark W. Chapleau, Gisela Chelimsky, Thomas Chelimsky, William P. Cheshire, Victoria E. Claydon, Roy Freeman, David S. Goldstein, Michael J. Joyner, Horacio Kaufmann, Phillip A. Low, Lucy Norcliffe-Kaufmann, David Robertson, Cyndya A. Shibao, Wolfgang Singer, Howard Snapper, Steven Vernino & Satish R. Raj. (2019) Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society. Clinical Autonomic Research 30:1, pages 13-18.
Crossref
Crossref
Alexandru Barboi, Christopher H. Gibbons, Felicia Axelrod, Eduardo E. Benarroch, Italo Biaggioni, Mark W. Chapleau, Gisela Chelimsky, Thomas Chelimsky, William P. Cheshire, Victoria E. Claydon, Roy Freeman, David S. Goldstein, Michael J. Joyner, Horacio Kaufmann, Phillip A. Low, Lucy Norcliffe-Kaufmann, David Robertson, Cyndya A. Shibao, Wolfgang Singer, Howard Snapper, Steven Vernino & Satish R. Raj. (2020) Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society. Autonomic Neuroscience 223, pages 102550.
Crossref
Crossref
Amelia B. Thompson & Lisa C. Flowers. 2020. Sexually Transmitted Infections in Adolescence and Young Adulthood. Sexually Transmitted Infections in Adolescence and Young Adulthood
279
297
.
Tom T. Shimabukuro, John R. Su, Paige L. Marquez, Adamma Mba-Jonas, Jorge E. Arana & Maria V. Cano. (2019) Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics 144:6.
Crossref
Crossref
S. Marshall, L.J. Sahm, A.C. Moore & A. Fleming. (2019) A systematic approach to map the adolescent human papillomavirus vaccine decision and identify intervention strategies to address vaccine hesitancy. Public Health 177, pages 71-79.
Crossref
Crossref
Yuxi Jia, Cong Zhu, Jingcheng Du, Yang Xiang, Yong Chen, Wei Wang & Cui Tao. (2019) Investigating safety profiles of human papillomavirus vaccine across group differences using VAERS data and MedDRA. PeerJ 7, pages e7490.
Crossref
Crossref
John R. Su, Jonathan Duffy & Tom T. Shimabukuro. 2019. Vaccinations. Vaccinations
1
24
.
Kayla E Hanson, Brandon Koch, Kimberly Bonner, Annie-Laurie McRee & Nicole E Basta. (2018) National Trends in Parental Human Papillomavirus Vaccination Intentions and Reasons for Hesitancy, 2010–2015. Clinical Infectious Diseases 67:7, pages 1018-1026.
Crossref
Crossref
A. P. Ruban & A. N. Pampura. (2018) ANAPHYLAXIS AND VACCINATION: RISKS AND REALITIES. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 63:4, pages 15-22.
Crossref
Crossref
. (2018) Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee. Public Health Reports 133:5, pages 543-550.
Crossref
Crossref
Samara Perez, Gregory D. Zimet, Ovidiu Tatar, Nathan W. Stupiansky, William A. Fisher & Zeev Rosberger. (2018) Human Papillomavirus Vaccines: Successes and Future Challenges. Drugs 78:14, pages 1385-1396.
Crossref
Crossref
Polona J. Maver & Mario Poljak. (2018) Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review. Vaccine 36:36, pages 5416-5423.
Crossref
Crossref
W Katherine Yih, Judith C Maro, Michael Nguyen, Meghan A Baker, Carolyn Balsbaugh, David V Cole, Inna Dashevsky, Adamma Mba-Jonas & Martin Kulldorff. (2018) Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System. American Journal of Epidemiology 187:6, pages 1269-1276.
Crossref
Crossref
Michelle L. Henninger, Jennifer L. Kuntz, Alison J. Firemark, Alexandra M. Varga, Karin Bok & Allison L. Naleway. (2018) Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination. Vaccine 36:27, pages 3937-3942.
Crossref
Crossref
Jorge L Cervantes & Amy Hoanganh Doan. (2018) Discrepancies in the evaluation of the safety of the human papillomavirus vaccine. Memórias do Instituto Oswaldo Cruz 113:8.
Crossref
Crossref
Kristine Macartney, Anastasia Phillips, Cyra Patel, Alexis Pillsbury & Julia Brotherton. (2018) Authors’ reply: Safety of Human Papillomavirus Vaccines. Drug Safety 41:5, pages 541-543.
Crossref
Crossref
Anastasia Phillips, Cyra Patel, Alexis Pillsbury, Julia Brotherton & Kristine Macartney. (2017) Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Safety 41:4, pages 329-346.
Crossref
Crossref
Gregory Zimet, Brian E. Dixon, Shan Xiao, Wanzhu Tu, Amit Kulkarni, Tamara Dugan, Meena Sheley & Stephen M. Downs. (2018) Simple and Elaborated Clinician Reminder Prompts for Human Papillomavirus Vaccination: A Randomized Clinical Trial. Academic Pediatrics 18:2, pages S66-S71.
Crossref
Crossref
Lauri E. Markowitz, Julianne Gee, Harrell Chesson & Shannon Stokley. (2018) Ten Years of Human Papillomavirus Vaccination in the United States. Academic Pediatrics 18:2, pages S3-S10.
Crossref
Crossref
Julia M.L. Brotherton & Paul N. Bloem. (2018) Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage. Best Practice & Research Clinical Obstetrics & Gynaecology 47, pages 42-58.
Crossref
Crossref
Noel T. Brewer, Gretchen B. Chapman, Alexander J. Rothman, Julie Leask & Allison Kempe. (2018) Increasing Vaccination: Putting Psychological Science Into Action. Psychological Science in the Public Interest 18:3, pages 149-207.
Crossref
Crossref
T. K. Eggersmann, J. Gallwas, S. Mahner & C. Dannecker. (2017) Impfung gegen humane Papillomviren. Wirksamkeit und NebenwirkungenHuman papillomavirus vaccines. Efficacy and adverse effects. Der Gynäkologe 50:9, pages 682-686.
Crossref
Crossref
Ulrike Wieland. (2017) Impfung birgt großes Potenzial. Der Deutsche Dermatologe 65:4, pages 272-284.
Crossref
Crossref
Georgios Androutsopoulos. (2017) Crossroads of Primary and Secondary Cervical Cancer Prevention Strategies in Resource-Constrained Settings. Journal of Cancer Prevention & Current Research 7:4.
Crossref
Crossref
Lai-yang Lee & Suzanne M. Garland. (2017) Human papillomavirus vaccination: the population impact. F1000Research 6, pages 866.
Crossref
Crossref
Cibelle Carneiro Farias, Dkaion Vilela Jesus, Hendel Santana Moraes, Ingrid Ferreira Buttenbender, Isabella Seixas Martins, Mayara Gabrielle Souto, Paulo Henrique Brasil Hass Gonçalves Filho, Randielly Mendonça Costa, Sarah de Oliveira Silva, Thais Suelen Israel Ferreira, Valéria Vieira da Silva Coutinho, Helvia Rochelle Tavora Minotto & Allex Jardim Fonseca. (2016) Factors related to non-compliance to HPV vaccination in Roraima—Brazil: a region with a high incidence of cervical cancer. BMC Health Services Research 16:1.
Crossref
Crossref